The Workshop on Drugs Pricing is a well-established event dedicated to exploring the main factors influencing processes for accessing, evaluating, and defining the pricing and reimbursement conditions of drugs in Italy.

The 12th edition takes place at a time of significant system-wide transformation, and over the course of two days, it will provide an overview of the key changes impacting drug governance, the evolution of evaluation processes, initial evidence of the application of the new European context, and other emerging dynamics relating to innovation, sustainability, and access organization in Italy.

The sessions will be linked by topics such as value recognition criteria, the role of evidence, and the transformation of evaluation models. There will be a specific focus on the more technical aspects of the P&R process, with in-depth analysis of methodological and operational interpretation issues to offer useful insights for navigating the ever-changing regulatory framework.

As in previous years, the Workshop on Drugs Pricing provides a platform for reflection and discussion among various stakeholders in the sector, with the aim of promoting a shared understanding of the changes taking place. The program combines regulatory updates, technical discussions, and practical applications to facilitate increasingly sustainable access to innovation that aligns with the needs of the system.